s 2337 has been researched along with n(alpha)-phosphorylalanylproline in 1 studies
Studies (s 2337) | Trials (s 2337) | Recent Studies (post-2010) (s 2337) | Studies (n(alpha)-phosphorylalanylproline) | Trials (n(alpha)-phosphorylalanylproline) | Recent Studies (post-2010) (n(alpha)-phosphorylalanylproline) |
---|---|---|---|---|---|
9 | 0 | 0 | 8 | 0 | 0 |
Protein | Taxonomy | s 2337 (IC50) | n(alpha)-phosphorylalanylproline (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.7763 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hemker, HC; Hendrix, HH; Kolde, HJ; Wagenvoord, RJ | 1 |
1 other study(ies) available for s 2337 and n(alpha)-phosphorylalanylproline
Article | Year |
---|---|
Development of a rapid and sensitive chromogenic heparin assay for clinical use.
Topics: Anticoagulants; Antithrombin III; Blood Coagulation Factors; Calcium Chloride; Calibration; Chromogenic Compounds; Dermatan Sulfate; Dextran Sulfate; Dipeptides; Drug Stability; Factor IXa; Heparin; Humans; Oligopeptides; Phospholipids; Platelet Factor 4; Sensitivity and Specificity | 1993 |